$1.660
-0.030 (-1.78%)Al cierre
Comparativa sectorial de OSTX
In the context of the broader market, OSTX competes directly with industry leaders such as GANX and LONA. With a market capitalization of $74.72M, it holds a significant position in the sector. When comparing efficiency, OSTX's gross margin of N/A stands against GANX's N/A and LONA's N/A. Such benchmarking helps identify whether OS Therapies Inc is trading at a premium or discount relative to its financial performance.
Desempeño financiero de OS Therapies Inc
The company has reported consistent net losses, with Q1 2026 showing a net operating loss of $10.4 million, a 167% increase from the previous year, indicating significant challenges in achieving profitability.
Financials
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.